Content area

|
|

Genomisk medicin og kræft

Forfatter(e)
Stig E. Bojesen1, 2 1) Klinisk Biokemisk Afdeling, Herlev og Gentofte Hospital 2) Institut for Klinisk Medicin, SUND, Københavns Universitet

Ugeskr Læger 2019;181:V12180852
Reference: 
Ugeskr Læger 2019;181:V12180852
Blad nummer: 

Stig E. Bojesen:

Genomic medicine and cancer

Ugeskr Læger 2019;181:V12180852

Our genomic understanding of cancer evolves quickly, driven by technological advances. Insights are added every day, but their interpretations are based on fundamental hypotheses on heredity and cell biology formulated more than 100 years ago. Genomic medicine is already in some use, but data from extremely large experiments of 100,000s of patients, controls, and tumours will alter the whole management of cancer; from early detection programmes before diagnosis, to efficient diagnostics, targeted treatment, response surveillance and monitoring of relapse.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Stefan Svendsen | 30/07
3 kommentarer
af Leo Kirkegaard Winther | 28/07
17 kommentarer
af Ann-Christina Skyttebo Scheffmann | 26/07
1 Kommentar
af Birger Kreutzfeldt | 23/07
10 kommentarer
af Susanne Mejlby Nielsen | 19/07
2 kommentarer
af Toke Seierøe Barfod | 17/07
1 Kommentar
af Betina Damsgaard | 12/07
1 Kommentar
af Preben G. Berthelsen | 12/07
1 Kommentar
af Eskild Boeskov | 11/07
6 kommentarer